PureTech Health (LON:PRTC) Shares Pass Above 50 Day Moving Average – Time to Sell?

PureTech Health plc (LON:PRTC) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 123.28 and traded as high as GBX 131.20. PureTech Health shares last traded at GBX 130.60, with a volume of 5,188,465 shares changing hands.

PureTech Health Trading Up 5.0%

The company has a debt-to-equity ratio of 6.33, a current ratio of 6.59 and a quick ratio of 2.51. The company has a fifty day moving average of GBX 123.66 and a 200-day moving average of GBX 125.72. The firm has a market capitalization of £334.94 million, a PE ratio of -2.99 and a beta of 0.79.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.